Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching - Takeaways - MDSpire

Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching

  • By

  • Chao Wei

  • Shuhua Zhou

  • Longyu Zhu

  • Jie Kong

  • Zimeng Gao

  • Danyang Wang

  • Deyou Kong

  • Andu Zhang

  • Shuo Pan

  • Kaiye Du

  • Dongxing Shen

  • Jun Zhang

  • Zhikun Liu

  • December 26, 2025

  • 0 min

Share

  • 1

    Breast cancer with ipsilateral supraclavicular lymph node metastasis (ISLM) is classified as locally advanced and indicates a poor prognosis.

  • 2

    The study analyzed the efficacy of radiotherapy alone versus combined surgery and radiotherapy for patients with sISLM breast cancer.

  • 3

    A total of 326 female patients with sISLM were included, with 238 receiving radiotherapy alone and 88 undergoing surgery plus radiotherapy.

  • 4

    The study aimed to explore optimal local treatment strategies for sISLM breast cancer to improve clinical decision-making.

  • 5

    Advancements in systemic treatments have improved the prognosis for ISLM breast cancer, but local management strategies remain debated.

Original Source(s)

Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching

  • by Chao Wei, Shuhua Zhou, Longyu Zhu, Jie Kong, Zimeng Gao, Danyang Wang, Deyou Kong, Andu Zhang, Shuo Pan, Kaiye Du, Dongxing Shen, Jun Zhang, Zhikun Liu

  • December 26, 2025

Related Content

Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min
HiGATE: hierarchical graph attention for multi-scale tissue encoder in computational pathology